Sigachi Industries [SIGACHI] vs Windlas Biotech [WINDLAS] Detailed Stock Comparison

Sigachi Industries
NSE
Loading...

Windlas Biotech
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sigachi Industries wins in 10 metrics, Windlas Biotech wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
Metric | Sigachi Industries | Windlas Biotech | Better |
---|---|---|---|
P/E Ratio (TTM) | 18.82 | 34.01 | Sigachi Industries |
Price-to-Book Ratio | 1.88 | 4.34 | Sigachi Industries |
Debt-to-Equity Ratio | 23.21 | 6.45 | Windlas Biotech |
PEG Ratio | -0.02 | 1.12 | Sigachi Industries |
EV/EBITDA | 12.09 | 19.37 | Sigachi Industries |
Profit Margin (TTM) | -8.44% | 8.20% | Windlas Biotech |
Operating Margin (TTM) | 15.11% | 9.08% | Sigachi Industries |
EBITDA Margin (TTM) | 15.11% | 9.08% | Sigachi Industries |
Return on Equity | 11.35% | 12.06% | Windlas Biotech |
Return on Assets (TTM) | 8.22% | 8.02% | Sigachi Industries |
Free Cash Flow (TTM) | $-163.98M | $159.93M | Windlas Biotech |
Dividend Yield | 0.18% | 1.23% | Windlas Biotech |
1-Year Return | -48.69% | 24.64% | Windlas Biotech |
Price-to-Sales Ratio (TTM) | 2.25 | 2.76 | Sigachi Industries |
Enterprise Value | $12.53B | $19.88B | Windlas Biotech |
EV/Revenue Ratio | 2.41 | 2.50 | Sigachi Industries |
Gross Profit Margin (TTM) | 51.03% | 38.25% | Sigachi Industries |
Revenue per Share (TTM) | $15 | $380 | Windlas Biotech |
Earnings per Share (Diluted) | $-0.97 | $30.80 | Windlas Biotech |
Beta (Stock Volatility) | 0.43 | 0.28 | Windlas Biotech |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sigachi Industries vs Windlas Biotech Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Sigachi Industries | 0.75% | -6.18% | -26.17% | -30.55% | -15.23% | -39.23% |
Windlas Biotech | 2.22% | 13.63% | 14.98% | 4.29% | 36.23% | 0.34% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Sigachi Industries | -48.69% | -89.36% | -94.59% | -94.59% | -94.59% | -94.59% |
Windlas Biotech | 24.64% | 389.60% | 185.66% | 185.66% | 185.66% | 185.66% |
Performance & Financial Health Analysis: Sigachi Industries vs Windlas Biotech
Metric | SIGACHI | WINDLAS |
---|---|---|
Market Information | ||
Market Cap | ₹11.72B | ₹21.95B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 6,515,818 | 153,326 |
90 Day Avg. Volume | 7,307,982 | 90,007 |
Last Close | ₹30.90 | ₹1,070.80 |
52 Week Range | ₹30.51 - ₹62.94 | ₹665.10 - ₹1,198.25 |
% from 52W High | -50.91% | -10.64% |
All-Time High | ₹634.00 (Nov 15, 2021) | ₹1,198.25 (Nov 04, 2024) |
% from All-Time High | -95.13% | -10.64% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.34% | 0.20% |
Quarterly Earnings Growth | N/A | 0.31% |
Financial Health | ||
Profit Margin (TTM) | -0.08% | 0.08% |
Operating Margin (TTM) | 0.15% | 0.09% |
Return on Equity (TTM) | 0.11% | 0.12% |
Debt to Equity (MRQ) | 23.21 | 6.45 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹16.31 | ₹241.38 |
Cash per Share (MRQ) | ₹1.89 | ₹114.20 |
Operating Cash Flow (TTM) | ₹498.99M | ₹396.84M |
Levered Free Cash Flow (TTM) | ₹695.63M | ₹609.94M |
Dividends | ||
Last 12-Month Dividend Yield | 0.18% | 1.23% |
Last 12-Month Dividend | ₹0.10 | ₹11.30 |
Valuation & Enterprise Metrics Analysis: Sigachi Industries vs Windlas Biotech
Metric | SIGACHI | WINDLAS |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 18.82 | 34.01 |
Forward P/E | N/A | N/A |
PEG Ratio | -0.02 | 1.12 |
Price to Sales (TTM) | 2.25 | 2.76 |
Price to Book (MRQ) | 1.88 | 4.34 |
Market Capitalization | ||
Market Capitalization | ₹11.72B | ₹21.95B |
Enterprise Value | ₹12.53B | ₹19.88B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.41 | 2.50 |
Enterprise to EBITDA | 12.09 | 19.37 |
Risk & Other Metrics | ||
Beta | 0.43 | 0.28 |
Book Value per Share (MRQ) | ₹16.31 | ₹241.38 |
Financial Statements Comparison: Sigachi Industries vs Windlas Biotech
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | SIGACHI | WINDLAS |
---|---|---|
Revenue/Sales | ₹1.28B | ₹2.03B |
Cost of Goods Sold | ₹509.66M | ₹1.25B |
Gross Profit | ₹772.39M | ₹775.14M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹238.13M | ₹172.13M |
EBITDA | ₹307.45M | ₹304.85M |
Pre-Tax Income | ₹226.72M | ₹208.23M |
Income Tax | ₹64.99M | ₹45.42M |
Net Income (Profit) | ₹161.73M | ₹162.81M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | SIGACHI | WINDLAS |
---|---|---|
Cash & Equivalents | ₹172.84M | ₹4.24M |
Total Current Assets | ₹3.94B | ₹5.25B |
Total Current Liabilities | ₹1.85B | ₹2.49B |
Long-Term Debt | ₹216.14M | ₹22.51M |
Total Shareholders Equity | ₹6.13B | ₹5.06B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹3.14B | ₹2.19B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | SIGACHI | WINDLAS |
---|---|---|
Operating Cash Flow | ₹-7.48M | N/A |
Capital Expenditures | ₹-31.96M | N/A |
Free Cash Flow | ₹-28.47M | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | SIGACHI | WINDLAS |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 6,515,818 | 153,326 |
Average Daily Volume (90 Day) | 7,307,982 | 90,007 |
Shares Outstanding | 382.12M | 20.96M |
Float Shares | 146.01M | 7.85M |
% Held by Insiders | 0.50% | 0.64% |
% Held by Institutions | 0.00% | 0.10% |
Dividend Analysis & Yield Comparison: Sigachi Industries vs Windlas Biotech
Metric | SIGACHI | WINDLAS |
---|---|---|
Last 12-Month Dividend | ₹0.10 | ₹11.30 |
Last 12-Month Dividend Yield | 0.18% | 1.23% |
3-Year Avg Annual Dividend | ₹0.04 | ₹6.27 |
3-Year Avg Dividend Yield | 0.06% | 0.96% |
3-Year Total Dividends | ₹0.12 | ₹18.80 |
Ex-Dividend Date | Aug 28, 2024 | Jul 21, 2025 |